CH649761A5 - Acides iminodiacetiques n-substitues. - Google Patents
Acides iminodiacetiques n-substitues. Download PDFInfo
- Publication number
- CH649761A5 CH649761A5 CH8210/81A CH821081A CH649761A5 CH 649761 A5 CH649761 A5 CH 649761A5 CH 8210/81 A CH8210/81 A CH 8210/81A CH 821081 A CH821081 A CH 821081A CH 649761 A5 CH649761 A5 CH 649761A5
- Authority
- CH
- Switzerland
- Prior art keywords
- compound according
- acid
- solution
- bromo
- amino
- Prior art date
Links
- 239000002253 acid Substances 0.000 title claims description 17
- 150000007513 acids Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 150000003839 salts Chemical class 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 14
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 12
- -1 4-bromo- 3-methylphenyl Chemical group 0.000 claims description 11
- 239000003638 chemical reducing agent Substances 0.000 claims description 8
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 8
- 229910014033 C-OH Inorganic materials 0.000 claims description 7
- 229910014570 C—OH Inorganic materials 0.000 claims description 7
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 239000011630 iodine Substances 0.000 claims description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical group II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 2
- UDLJWHHLPYMPPJ-UHFFFAOYSA-N 2-[[2-(3-bromo-2,6-diethyl-4-methylanilino)-2-oxoethyl]-(carboxymethyl)amino]acetic acid Chemical compound CCC1=CC(C)=C(Br)C(CC)=C1NC(=O)CN(CC(O)=O)CC(O)=O UDLJWHHLPYMPPJ-UHFFFAOYSA-N 0.000 claims 1
- SFPXBXKUJFHQQY-UHFFFAOYSA-N 2-[carboxymethyl-[2-(3-iodo-4-methylanilino)-2-oxoethyl]amino]acetic acid Chemical compound CC1=CC=C(NC(=O)CN(CC(O)=O)CC(O)=O)C=C1I SFPXBXKUJFHQQY-UHFFFAOYSA-N 0.000 claims 1
- MHPZZZZLAQGTHT-UHFFFAOYSA-N mebrofenin Chemical compound CC1=CC(C)=C(NC(=O)CN(CC(O)=O)CC(O)=O)C(C)=C1Br MHPZZZZLAQGTHT-UHFFFAOYSA-N 0.000 claims 1
- 239000000243 solution Substances 0.000 description 39
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 22
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 21
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 18
- GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 description 16
- 239000012153 distilled water Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000012043 crude product Substances 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 7
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 210000000941 bile Anatomy 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000002808 molecular sieve Substances 0.000 description 5
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- 238000009472 formulation Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- DJQJFMSHHYAZJD-UHFFFAOYSA-N lidofenin Chemical compound CC1=CC=CC(C)=C1NC(=O)CN(CC(O)=O)CC(O)=O DJQJFMSHHYAZJD-UHFFFAOYSA-N 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- 230000002285 radioactive effect Effects 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 4
- 229960002799 stannous fluoride Drugs 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- MVLMPTBHZPYDBZ-UHFFFAOYSA-N 3-bromo-2,4,6-trimethylaniline Chemical compound CC1=CC(C)=C(Br)C(C)=C1N MVLMPTBHZPYDBZ-UHFFFAOYSA-N 0.000 description 2
- FCFLPZAAPZHJKJ-UHFFFAOYSA-N 3-bromo-2,6-diethyl-4-methylaniline Chemical compound CCC1=CC(C)=C(Br)C(CC)=C1N FCFLPZAAPZHJKJ-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 210000003445 biliary tract Anatomy 0.000 description 2
- 238000010668 complexation reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 210000001865 kupffer cell Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 235000011837 pasties Nutrition 0.000 description 2
- 229960003330 pentetic acid Drugs 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 229940121896 radiopharmaceutical Drugs 0.000 description 2
- 239000012217 radiopharmaceutical Substances 0.000 description 2
- 230000002799 radiopharmaceutical effect Effects 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 125000003944 tolyl group Chemical group 0.000 description 2
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- LJRDOKAZOAKLDU-UDXJMMFXSA-N (2s,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(2r,3s,4r,5s)-5-[(1r,2r,3s,5r,6s)-3,5-diamino-2-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric ac Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO LJRDOKAZOAKLDU-UDXJMMFXSA-N 0.000 description 1
- PNDPGZBMCMUPRI-HVTJNCQCSA-N 10043-66-0 Chemical compound [131I][131I] PNDPGZBMCMUPRI-HVTJNCQCSA-N 0.000 description 1
- KWVPRPSXBZNOHS-UHFFFAOYSA-N 2,4,6-Trimethylaniline Chemical compound CC1=CC(C)=C(N)C(C)=C1 KWVPRPSXBZNOHS-UHFFFAOYSA-N 0.000 description 1
- OIXUMNZGNCAOKY-UHFFFAOYSA-N 2,6-diethyl-4-methylaniline Chemical compound CCC1=CC(C)=CC(CC)=C1N OIXUMNZGNCAOKY-UHFFFAOYSA-N 0.000 description 1
- GRXMMIBZRMKADT-UHFFFAOYSA-N 3-bromo-4-methylaniline Chemical compound CC1=CC=C(N)C=C1Br GRXMMIBZRMKADT-UHFFFAOYSA-N 0.000 description 1
- RRUDMHNAMZFNEK-UHFFFAOYSA-N 3-iodo-4-methylaniline Chemical compound CC1=CC=C(N)C=C1I RRUDMHNAMZFNEK-UHFFFAOYSA-N 0.000 description 1
- MMEGELSFOYDPQW-UHFFFAOYSA-N 4-bromo-3-methylaniline Chemical compound CC1=CC(N)=CC=C1Br MMEGELSFOYDPQW-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- ZOKXTWBITQBERF-AKLPVKDBSA-N Molybdenum Mo-99 Chemical compound [99Mo] ZOKXTWBITQBERF-AKLPVKDBSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 229910052925 anhydrite Inorganic materials 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- GHAFORRTMVIXHS-UHFFFAOYSA-L bromosulfophthalein sodium Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(O)=CC=C1C1(C=2C=C(C(O)=CC=2)S([O-])(=O)=O)C(C(Br)=C(Br)C(Br)=C2Br)=C2C(=O)O1 GHAFORRTMVIXHS-UHFFFAOYSA-L 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000001096 cystic duct Anatomy 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical compound OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229950009740 molybdenum mo-99 Drugs 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000009206 nuclear medicine Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229960001639 penicillamine Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 230000003335 steric effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960001734 sulfobromophthalein Drugs 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- IUTCEZPPWBHGIX-UHFFFAOYSA-N tin(2+) Chemical compound [Sn+2] IUTCEZPPWBHGIX-UHFFFAOYSA-N 0.000 description 1
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22115580A | 1980-12-29 | 1980-12-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH649761A5 true CH649761A5 (fr) | 1985-06-14 |
Family
ID=22826582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH8210/81A CH649761A5 (fr) | 1980-12-29 | 1981-12-22 | Acides iminodiacetiques n-substitues. |
Country Status (15)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4454107A (en) * | 1982-08-30 | 1984-06-12 | Merck & Co., Inc. | Tc99m-Phenida, radioscintigraphic agent for diagnosis of hepatoniliary disease |
| GB8413772D0 (en) * | 1984-05-30 | 1984-07-04 | Nyegaard & Co As | Chemical compounds |
| JPH0331486Y2 (enrdf_load_stackoverflow) * | 1985-06-24 | 1991-07-04 | ||
| JPH01143751A (ja) * | 1987-11-18 | 1989-06-06 | Corns & Co Ltd | 低圧鋳造装置とその鋳造方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3725295A (en) * | 1971-07-20 | 1973-04-03 | Atomic Energy Commission | Technetium labeling |
| US4017596A (en) * | 1975-03-03 | 1977-04-12 | Research Corporation | Radiopharmaceutical chelates and method of external imaging |
| CA1070695A (en) * | 1975-09-02 | 1980-01-29 | Michael D. Loberg | Iminodiacetic acid pharmaceutical |
| CH607920A5 (enrdf_load_stackoverflow) * | 1976-05-31 | 1978-12-15 | Solco Basel Ag | |
| PL115524B1 (en) * | 1978-04-10 | 1981-04-30 | Uniwersytet Warszawski | Process for manufacturing scintigraphic agent |
| DE2855334A1 (de) * | 1978-12-21 | 1980-07-10 | Hoechst Ag | Technetium-99m-markiertes (2,4,5-trimethylacetanilido)-iminodiacetat zur leberfunktionsdiagnostik und verfahren zur herstellung |
| DE2920174A1 (de) * | 1979-05-18 | 1980-11-20 | Hoechst Ag | Technetium-99m-markierte acetanilidoiminodiacetate zur leberfunktionsdiagnostik |
-
1981
- 1981-12-10 CA CA000392015A patent/CA1187897A/en not_active Expired
- 1981-12-17 GB GB8138054A patent/GB2090252B/en not_active Expired
- 1981-12-18 IE IE3110/81A patent/IE52900B1/en not_active IP Right Cessation
- 1981-12-18 BE BE0/206879A patent/BE891534A/fr not_active IP Right Cessation
- 1981-12-21 FR FR8123803A patent/FR2497197B1/fr not_active Expired
- 1981-12-22 CH CH8210/81A patent/CH649761A5/fr not_active IP Right Cessation
- 1981-12-23 AU AU78808/81A patent/AU539726B2/en not_active Expired
- 1981-12-23 JP JP56216075A patent/JPS58948A/ja active Granted
- 1981-12-24 NL NL8105845A patent/NL193318C/nl not_active IP Right Cessation
- 1981-12-24 LU LU83856A patent/LU83856A1/fr unknown
- 1981-12-28 IT IT25861/81A patent/IT1140400B/it active
- 1981-12-28 ZA ZA818943A patent/ZA818943B/xx unknown
- 1981-12-28 DE DE19813151686 patent/DE3151686A1/de active Granted
- 1981-12-28 SE SE8107806A patent/SE461015B/sv not_active IP Right Cessation
- 1981-12-29 AT AT0561381A patent/AT377975B/de active
-
1987
- 1987-09-18 SE SE8703623A patent/SE466788B/sv not_active IP Right Cessation
-
1989
- 1989-09-28 JP JP1256895A patent/JPH02160727A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DE3151686A1 (de) | 1982-07-08 |
| NL193318C (nl) | 1999-06-02 |
| JPS58948A (ja) | 1983-01-06 |
| AT377975B (de) | 1985-05-28 |
| JPH0237345B2 (enrdf_load_stackoverflow) | 1990-08-23 |
| SE8107806L (sv) | 1982-06-30 |
| SE8703623L (sv) | 1987-09-18 |
| NL193318B (nl) | 1999-02-01 |
| GB2090252A (en) | 1982-07-07 |
| FR2497197A1 (fr) | 1982-07-02 |
| DE3151686C2 (enrdf_load_stackoverflow) | 1990-12-20 |
| ATA561381A (de) | 1984-10-15 |
| BE891534A (fr) | 1982-04-16 |
| AU539726B2 (en) | 1984-10-11 |
| SE8703623D0 (sv) | 1987-09-18 |
| GB2090252B (en) | 1985-01-03 |
| CA1187897A (en) | 1985-05-28 |
| AU7880881A (en) | 1982-07-08 |
| IE813110L (en) | 1982-06-29 |
| LU83856A1 (fr) | 1982-07-07 |
| SE461015B (sv) | 1989-12-18 |
| FR2497197B1 (fr) | 1986-04-11 |
| IE52900B1 (en) | 1988-04-13 |
| SE466788B (sv) | 1992-04-06 |
| IT1140400B (it) | 1986-09-24 |
| JPH02160727A (ja) | 1990-06-20 |
| NL8105845A (nl) | 1982-07-16 |
| ZA818943B (en) | 1982-11-24 |
| JPH0316327B2 (enrdf_load_stackoverflow) | 1991-03-05 |
| IT8125861A0 (it) | 1981-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0287465B1 (fr) | Ligands cycliques azotés, complexes métalliques formés par ces ligands, compositions de diagnostic contenant ces complexes et procédé de préparation des ligands | |
| US4760173A (en) | NMR contrast agents | |
| EP2086924B1 (de) | [f-18]markierte l-glutaminsäure, [f-18]markiertes l-glutamin, ihre derivate und ihre verwendung sowie verfahren zu ihrer herstellung | |
| EP0391766B1 (fr) | Nouveaux ligands macrocycliques azotés, procédé de préparation, complexes métalliques formés par ces ligands, composition de diagnostic et composition thérapeutique les contenant | |
| US5138039A (en) | Chelating compounds and their use | |
| JPH07242615A (ja) | エーテル置換イソニトリルおよびその製法 | |
| JPH02104588A (ja) | ５員‐又は６員‐環を有する巨大環状ポリアザ‐化合物、その製法及びこれを含有するｎｍｒ‐、ｘ線‐、放射線‐診断用及び放射能‐及び照射線‐治療用薬剤及びこの薬剤の製法 | |
| KR100745445B1 (ko) | 종양 영상화 화합물 | |
| US4418208A (en) | N-Substituted iminodiacetic acids | |
| EP2643301B1 (fr) | Complexe de technetium 99m en tant qu'outil de diagnostic in vivo des tumeurs cancereuses | |
| FR2655339A2 (fr) | Composes et complexes utiles notamment en imagerie medicale. | |
| CH649761A5 (fr) | Acides iminodiacetiques n-substitues. | |
| WO1996030054A1 (en) | 99mTc - LABELLED SEROTONIN RECEPTOR BINDING SUBSTANCES | |
| EP0515670B1 (en) | Hexadentate ligands useful in radiographic imaging agents | |
| EP0365412B1 (fr) | Nouveaux ligands cycliques azotés, complexes métalliques formés par ces ligands, compositions de diagnostic contenant ces complexes et procédé de préparation des ligands | |
| US5274082A (en) | Paramagnetic complexes of chelating compounds | |
| EP0465295A1 (fr) | Agent de contraste pour l'imagerie par RMN et agents chélateurs comportant des structures peptidiques | |
| WO1990002571A1 (fr) | Produits radiopharmaceutiques constitues par des complexes tetraphosphonates | |
| JP2000302795A (ja) | 放射性遷移金属で標識された脂肪酸誘導体 | |
| JPH08508262A (ja) | 放射性同位体のためのタイプｓ３ｎ２キレート剤、それらの金属錯体、及びそれらの診断及び治療への使用 | |
| JPH07502501A (ja) | Ｎ−置換３−ヒドロキシ−４−ピリジノン類によるテクネチウム−９９ｍ錯体 | |
| JPH05221958A (ja) | 核医学に使用することができる核種のための錯化剤としてのジアミノメルカプト（チオ）エーテル | |
| JPH0797361A (ja) | 新規なキレート形成性化合物とその用途 | |
| JPS5946264A (ja) | 分子中にキレ−ト形成基とアミノ基またはアルキルアミノ基を有する新規化合物 | |
| JPH0797362A (ja) | 新規なキレート形成性化合物とその用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUE | Assignment |
Owner name: BRACCO INTERNATIONAL B.V. |
|
| PFA | Name/firm changed |
Owner name: BRACCO INTERNATIONAL B.V.,7, DE BOELELAAN,AMSTERDA |
|
| PL | Patent ceased |